A complex secretory program orchestrated by the inflammasome controls paracrine senescence
Open accessThe DOI matches its Crossref record; 53 of the 54 references it cites were found in a registry or an index; 20 of the 36 sources its claims cite were checked for support.
Abstract
Oncogene-induced senescence (OIS) is crucial for tumour suppression. Senescent cells implement a complex pro-inflammatory response termed the senescence-associated secretory phenotype (SASP). The SASP reinforces senescence, activates immune surveillance and paradoxically also has pro-tumorigenic properties. Here, we present evidence that the SASP can also induce paracrine senescence in normal cells both in culture and in human and mouse models of OIS in vivo. Coupling quantitative proteomics with small-molecule screens, we identified multiple SASP components mediating paracrine senescence, including TGF-β family ligands, VEGF, CCL2 and CCL20. Amongst them, TGF-β ligands play a major role by regulating p15(INK4b) and p21(CIP1). Expression of the SASP is controlled by inflammasome-mediated IL-1 signalling. The inflammasome and IL-1 signalling are activated in senescent cells and IL-1α expression can reproduce SASP activation, resulting in senescence. Our results demonstrate that the SASP can cause paracrine senescence and impact on tumour suppression and senescence in vivo.
Overview
CoChat Summary
## TL;DR
Cells undergoing oncogene-induced senescence (OIS) can transmit senescence to neighboring normal cells through secreted SASP factors, creating a stable paracrine senescence state in culture and in vivo. The paper identifies TGFβ family ligands and IL-1/inflammasome signaling as key regulators of this process.
## Key findings
- Normal IMR90 fibroblasts and HMECs became growth-arrested when co-cultured with OIS cells; the effect was transmitted through transwells and conditioned media, showing it was mediated by soluble factors rather than direct contact.
- Paracrine senescence resembled full senescence: normal cells showed increased DNA/oxidative damage, p16^INK4a^, p21^CIP1^, and SASP markers; gene-expression profiles of OIS and paracrine senescence were highly correlated and clustered together.
- Quantitative proteomics and a 78-compound screen implicated multiple SASP components in paracrine senescence, including TGFβ family ligands, VEGF, CCL2, and CCL20; blocking VEGFR2/FLT3, TGFBR1, or CCR2 partially impaired the arrest.
- The paper reports specific in vivo evidence of paracrine senescence: p21^CIP1^+/p16^INK4a^ cells were found near OIS lesions in mouse liver and skin, and in human serrated sessile adenomas the stromal p21^CIP1^/Ki-67^- signal was significantly increased near lesions (p = 0.03), with a separate comparison reporting p = 4.6 × 10^-5^ for p21^CIP1^ positive/Ki67 negative stromal cells.
## Methods
- Co-culture, transwell, conditioned-media, and cluster assays were used in human IMR90 fibroblasts and HMECs; OIS was induced with ER:RAS, MEK:ER, or related oncogenic constructs activated by 4OHT.
- Secretome analysis used SILAC-based quantitative proteomics, followed by a 78-compound receptor/pathway screen, RNAi knockdown, RT-qPCR, microarrays, GSEA, immunofluorescence/high-content analysis, and assays for BrdU, SA-β-Gal, caspase-1, and antibody arrays.
- In vivo validation used mouse OIS models including Nras-driven hepatocyte senescence, K5-Sos/Egfr^wa2/+^ skin papillomas, and Pdx1-Cre Kras^G12D^ pancreatic lesions, plus human SSA tissue IHC.
## Limitations
- The paper itself notes that “the nature of these cells and the functional implications of paracrine senescence remain open questions for future studies.”
- It also states that not all cells surrounding preneoplastic lesions undergo paracrine senescence; it proposes possible explanations such as soluble-factor gradients and cell-type susceptibility, but these are not experimentally resolved here.
- Evident from the text: many mechanistic and inhibitor results are partial (“partially rescued,” “partially prevented”), so the study does not identify a single exclusive mediator of paracrine senescence.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Valid · 1 Not valid · 7 Not checked · 78 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“a transcriptional signature associated with senescence 18 was significantly upregulated during paracrine senescence (Fig 3d).”
§ Current address: Edinburgh Cancer Research UK Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Crewe Road South, Edinburgh EH4 2XR, UK > Paracrine senescence resembles a full senescence response
What the sources say
- Supportedcites [18] Fridman AL, Tainsky MA. Critical pathways in cellular senescence and immortalization revealed by gene expression profiling. Oncogene. 2008; 27:5975-87. [PubMed: 18711403] source
The 'Genomic approaches to identify senescence/immortalization genes and pathways' section describes gene-expression profiling that identifies genes and pathways associated with senescence. In the citing sentence, the citation identifies the senescence-associated transcriptional signature; the finding that it was significantly upregulated during paracrine senescence is attributed to the citing paper’s Fig. 3d, not to this source. No page number is available in our copy. (LLM, conf=0.87)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Colon SSAs are mainly driven by activating BRAF mutations that trigger OIS 31,34,35 .”
§ Current address: Edinburgh Cancer Research UK Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Crewe Road South, Edinburgh EH4 2XR, UK > Paracrine senescence is observed in mouse and human models of OIS in vivo
What the sources say
- Partly supportedcites [31] Carragher LA, et al. V600EBraf induces gastrointestinal crypt senescence and promotes tumour progression through enhanced CpG methylation of p16INK4a. EMBO Mol Med. 2010; 2:458-71. [PubMed: 20941790] sourceExperimental — accuracy not yet measured
The Discussion reports V600E BRAF mutations in approximately 70% of right-sided serrated hyperplastic polyps and serrated adenomas, supporting a major role for BRAF in the serrated pathway. The Results show that V600E Braf induces senescence in mouse small-intestinal crypts, but do not establish that BRAF mutations trigger OIS in human colon sessile serrated adenomas. (LLM, conf=0.87)
- Partly supportedcites [34] Kriegl L, et al. Up and downregulation of p16(Ink4a) expression in BRAF-mutated polyps/ adenomas indicates a senescence barrier in the serrated route to colon cancer. Modern Pathology. 2011; 24:1015-22. [PubMed: 21423154] sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) says that initiating BRAF mutations might drive oncogene-induced senescence in human serrated polyps, and concludes that the data provide evidence for senescence in the BRAF-mutated serrated route. It does not establish that colon sessile serrated adenomas are mainly driven by BRAF mutations: the study selected BRAF-mutated lesions for its final analysis, and its proposed causal link is hedged. (LLM, conf=0.85)
- Not checked — no full text of the sourcecites [35] Bennecke M, et al. Ink4a/Arf and oncogene-induced senescence prevent tumor progression during alternative colorectal tumorigenesis. Cancer Cell. 2010; 18:135-46. [PubMed: 20708155] source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“A signature derived from IMR90 cells undergoing paracrine senescence is found enriched in mouse PANIN 44 and human serrated sessile adenomas (SSA) 36 .”
§ Current address: Edinburgh Cancer Research UK Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Crewe Road South, Edinburgh EH4 2XR, UK > REFERENCES
What the sources say
- Partly supportedcites [44] Ling J, et al. KrasG12D-induced IKK2/beta/NF-kappaB activation by IL-1alpha and p62 feedforward loops is required for development of pancreatic ductal adenocarcinoma. Cancer Cell. 2012; 21:105-20. [PubMed: 22264792] sourceExperimental — accuracy not yet measured
The Results section, “Inhibition of Key Proinflammatory Cytokines,” reports gene-expression profiles from mouse PanIN, so this paper provides the mouse PanIN data cited as reference 44. It does not report testing or finding enrichment of an IMR90 paracrine-senescence signature in those profiles. The SSA finding is attached to a different citation (36), not this source. (LLM, conf=0.79)
- Not checked — no full text of the sourcecites [36] Caruso M, et al. Over-expression of cathepsin E and trefoil factor 1 in sessile serrated adenomas of the colorectum identified by gene expression analysis. Virchows Archiv. 2009; 454:291-302. [PubMed: 19172291] source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“we identified multiple SASP components mediating paracrine senescence, including TGF β family ligands, VEGF, CCL2 and CCL20.”
- Also stated in: § Abstract · plain
“Coupling quantitative proteomics with small molecule screens, we identified multiple SASP components mediating paracrine senescence, including TGF β family ligands, VEGF, CCL2 and CCL20.”
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Abstract · plain
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Expression of the SASP is controlled by inflammasome-mediated IL-1 signalling.”
states a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: unclear — It is unclear why the paper says it holds.
54 more claims
Create a free account to see all 101 claims and every source verdict.
- Probably not a substantial claim. 20
- It may state two separate claims as one. 21
- The quote only partly states this claim. 3
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The senescent cell fate can be triggered by a number of stressors including DNA damage, cancerous mutations or oncogene activation, mitochondrial dysfunction, reactive metabolites, hyperoxia or hypoxia, proteotoxic stress, extracellular signals, infections, mechanical or shear stresses that deform cells, resistance exercise and factors secreted by other senescent cells18,38–47.”
From Cellular senescence and senolytics: the path to the clinic (2022) · cites this paper as [39]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The inflammasome, a multiprotein complex comprising caspase 1 and key regulators of the defence mechanisms against pathogens117, and Toll-like receptors, which regulate the inflammasome, have been reported to promote maturation and secretion of SASP factors during OIS73,118.”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [73]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In addition, specific SASP components, either soluble or in extracellular vesicles186, can induce senescence in a paracrine manner — which includes DDR activation73,83.”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [73]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Upstream signals triggering SASP activation are multiple and differ depending on the senescence inducer but include DNA damage, cytoplasmic chromatin fragments (CCFs) that trigger a type 1 interferon response, and damage-associated molecular patterns (DAMPs) that activate the inflammasome (Acosta et al., 2013; Davalos et al., 2013; Li and Chen, 2018).”
From Cellular Senescence: Defining a Path Forward (2019) · cites this paper as Acosta et al., 2013
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Higher secretion of SASP factors is also associated with an enhanced immune response, leading to inflammation which may promote tumorigenesis (Acosta et al., 2013).”
From Single senescent cell sequencing reveals heterogeneity in senescent cells induced by telomere erosion (2019) · cites this paper as Acosta et al., 2013
Experimental — accuracy not yet measured
47 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
The serial cultivation of human diploid cell strains
Hayflick, L., & Moorhead, P. S. (1961) · Experimental Cell Research · doi:10.1016/0014-4827(61)90192-6 · Cited by 8,508
The limited in vitro lifetime of human diploid cell strains
Hayflick, L. (1965) · Experimental Cell Research · doi:10.1016/0014-4827(65)90211-9 · Cited by 5,876
Schroder, K., & Tschopp, J. (2010) · Cell · doi:10.1016/j.cell.2010.01.040 · Cited by 5,475
Cellular senescence: when bad things happen to good cells
Campisi, J., & d'Adda di Fagagna, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2233 · Cited by 4,441
Massagué, J. (2008) · Cell · doi:10.1016/j.cell.2008.07.001 · Cited by 3,907
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
Xue, W., Zender, L., Miething, C., Dickins, R. A., Hernando, E., Krizhanovsky, V., Cordon-Cardo, C., & Lowe, S. W. (2007) · Nature · doi:10.1038/nature05529 · Cited by 2,473
Self-citationPreinvasive and invasive ductal pancreatic cancer and its early detection in the mouse
Hingorani, S. R., Petricoin, E. F., Maitra, A., Rajapakse, V., King, C., Jacobetz, M. A., Ross, S., Conrads, T. P., Veenstra, T. D., Hitt, B. A., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00309-x · Cited by 2,471
Inflammasomes in health and disease
Strowig, T., Henao-Mejia, J., Elinav, E., & Flavell, R. (2012) · Nature · doi:10.1038/nature10759 · Cited by 2,230
Oncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network
Kuilman, T., Michaloglou, C., Vredeveld, L. C. W., Douma, S., van Doorn, R., Desmet, C. J., Aarden, L. A., Mooi, W. J., & Peeper, D. S. (2008) · Cell · doi:10.1016/j.cell.2008.03.039 · Cited by 2,086
Cited by
Items 1,701–1,800 of 2,275
Increased inflammation in older high-pressure glaucoma mice
Reinehr, S., Pamuk, M. R., Fuchshofer, R., Dick, H. B., & Joachim, S. C. (2024) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2024.10.001 · Cited by 4
Ruths, L., Hengge, J., Teixeira, G. Q., Haffner‐Luntzer, M., Ignatius, A. A., & Riegger, J. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1470907 · Cited by 5
Exline, J. E., Volyanyuk, M., Lotesto, K. M., Segismundo, A. B., Byram, S. C., & Foecking, E. M. (2025) · Brain Research · doi:10.1016/j.brainres.2025.149611 · Cited by 4
“As a result, neighboring cells are recruited into a senescent state through paracrine SASP signaling thereby exacerbating senescence-associated dysfunction in the tissue where these cells reside (Acosta et al., 2013; Kuilman et al., 2008; Ortiz-Montero et al., 2017).”
Liu, J., Li, H., Sun, R., Ying, G., & Liang, Z. (2025) · Cancer Cell International · doi:10.1186/s12935-025-03818-7 · Cited by 4
Ahead of their time: hyperoxia injury induces senescence in developing lung fibroblasts
Sucre, J. M. S., & Plosa, E. J. (2019) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00354.2019 · Cited by 3
Lactoferrin for the treatment of age-associated inflammation – A pilot study
Laskow, T. C., Langdon, J., Abadir, P. M., Xue, Q., & Walston, J. D. (2021) · Physiology International · doi:10.1556/2060.2021.00010 · Cited by 5
PD-1, a New Player in Podocyte Age-Related Senescence
Rangel, P. X. M., & Ishibe, S. (2022) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2022.10.007 · Cited by 4
Spreading Senescent Cells’ Burden and Emerging Therapeutic Targets for Frailty
Marcozzi, S., Bigossi, G., Giuliani, M. E., Lai, G., Giacconi, R., Piacenza, F., & Malavolta, M. (2023) · Cells · doi:10.3390/cells12182287 · Cited by 4
Wang, Y., Liu, Z., Pan, C., Zheng, Y., Chen, Y., Lian, X., Jiang, Y., Chen, C., Xue, K., Zhang, Y., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11102836 · Cited by 5
Regulation of Aging and Lifespan by White Adipose Tissue
Fukuoh, T., Nozaki, Y., Mizunoe, Y., & Higami, Y. (2024) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.23-00165-4 · Cited by 4
Antagonizing Activin A/p15INK4b Signaling as Therapeutic Strategy for Liver Disease
Mekala, S., Rai, R. P., Reed, S. L., Bowen, B., Michalopoulos, G. K., Locker, J. D., Raeman, R., & Oertel, M. (2024) · Cells · doi:10.3390/cells13070649 · Cited by 3
“Moreover, activin A was identified among multiple senescence-associated secretory phenotype (SASP) factors that mediate paracrine senescence [37].”
BackgroundMultiparametric identification of putative senescent cells in skeletal muscle via mass cytometry
Li, Y., Baig, N. F., Roncancio, D., Elbein, K., Lowe, D. A., Kyba, M., & Arriaga, E. A. (2024) · Cytometry Part A · doi:10.1002/cyto.a.24853 · Cited by 4
“Macrophages may not necessarily be senescent but may acquire SC-like phenotypes, they may be upregulated in response to stimuli that induce macrophage polarization, or may be affected by paracrine signals from SCs [25, 68 – 70].”
Gomez, L. S., & Jurk, D. (2024) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-031-66768-8_5 · Cited by 4
Cytokine-driven cancer immune evasion mechanisms
Arenas, E. J. (2025) · International review of cytology · doi:10.1016/bs.ircmb.2025.01.004 · Cited by 12
Wijayasiri, P., Astbury, S., Needham, G., Kaye, P., Bhat, M., Piccinini, A. M., & Aravinthan, A. D. (2025) · Human Cell · doi:10.1007/s13577-025-01201-2 · Cited by 5
“SASP factors, which promote inflammation, induce senescence in nearby damaged cells and eventually facilitate the removal of senescent cells [35], have also been shown to fuel proliferation of pre-malignant cells and malignant transformation [9, 10].”
Cellular senescence and chronic inflammation
Ohtani, N. (2014) · Japanese Journal of Clinical Immunology · doi:10.2177/jsci.37.390 · Cited by 3
SASP: roadblock for tissue re-organization
Cahu, J. (2013) · Aging · doi:10.18632/aging.100602 · Cited by 3
Oncogene‐induced cellular senescence elicits an anti‐ W arburg effect
Banks, R. E. (2013) · PROTEOMICS · doi:10.1002/pmic.201300335 · Cited by 3
Targeting Senescent Cells to Improve Human Health
Wijshake, T., & van Deursen, J. M. A. (2016) · Healthy ageing and longevity · doi:10.1007/978-3-319-26239-0_16 · Cited by 3
“Fourth, induction of senescence in neighboring cells (paracrine senescence); agerelated tissue dysfunction can be exacerbated by senescent cell secretion of TGF-“, VEGF, CCL2, CCL20, IL-1’ and ROS that are capable to provoke senescence in healthy neighboring cells and hereby spread senescence to the environment (Nelso…”
BackgroundLi, Y., Wei, Y., Yuan, W., Huang, Q., Zhao, Y., Zhao, W., Xu, W. D., & Wu, J. (2018) · Oncology Reports · doi:10.3892/or.2018.6310 · Cited by 5
“Some SASP factors can reinforce senescent growth arrest in an autocrine manner (36).”
BackgroundCellular Senescence and Tumor Promotion
Demaria, M. (2020) · Springer eBooks · doi:10.1007/978-3-319-57415-8_79 · Cited by 4
Mazini, L., Rochette, L., & Malka, G. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.91233 · Cited by 5
Gennai, A., Gennai, A., Bovani, B., et al. (2021) · International Journal of Regenerative Medicine · doi:10.31487/j.rgm.2021.02.02 · Cited by 3
Gargani, S., Lourou, N., Arapatzi, C., Tzanos, D., Saridaki, M., Dushku, E., Chatzimike, M., Sidiropoulos, N. D., Andreadou, M., Ntafis, V., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.752215 · Cited by 4
“Moreover, the activation of inflammasomes can support a specialized form of cell death called pyroptosis which can feedback to enhance the damaging response (28, 29).”
BackgroundPicallos-Rabina, P., Silva‐Álvarez, S. D., Antelo-Iglesias, L., Triana-Martínez, F., & Collado, M. (2020) · Healthy ageing and longevity · doi:10.1007/978-3-030-44903-2_5 · Cited by 3
Transcription-driven cohesin repositioning rewires chromatin loops in cellular senescencePreprint
Olan, I., Parry, A., Schoenfelder, S., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/823831 · Cited by 3
Silva‐Álvarez, S. D., & Collado, M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-394447-4.30066-9 · Cited by 5
Cytokine Receptors and Their Ligands
Shing, K. S. C. T., Kan, W. L., Nero, T. L., Hercus, T. R., Tvorogov, D., Metcalfe, R. D., Griffin, M. D. W., de Weerd, N. A., Guthridge, M. A., Hertzog, P. J., et al. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-821618-7.00079-1 · Cited by 3
Silva‐Álvarez, S. D., & Collado, M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-821618-7.00219-4 · Cited by 3
Ciotlos, S., Wimer, L. A., Campisi, J., & Melov, S. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.02.17.529001 · Cited by 4
“The SASP is a pro-inflammatory profile that leads to alterations in tissue microenvironment and paracrine transmission of cell senescence [2, 25-27] .”
BackgroundHom, L. M., Sun, S., Campbell, J., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.02.21.529458 · Cited by 3
Bei, J., Miranda-Morales, E. G., Gan, Q., Qiu, Y., Husseinzadeh, S., Liew, J. Y., Chang, Q., Krishnan, B., Gaitas, A., Yuan, S., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.04.03.535441 · Cited by 3
Hu, J., Yu, D., Wu, D., Wang, J., Cai, Y., Du, X., Ji, J., & Ouyang, H. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.04.15.537012 · Cited by 3
Jang, D., Shim, E., Shin, J., Kim, S., Ciotlos, S., Kim, H. J., Gil, T., Kim, Y., & Jeon, O. H. (2026) · Aging Cell · doi:10.1111/acel.70540 · Cited by 2
“Primary SnCs are induced directly by intrinsic stressors, such as DNA damage, whereas secondary SnCs arise through paracrine (Acosta et al. 2013; Nelson et al. 2012) or systemic signaling mechanisms driven by SASP factors released by primary SnCs (Jeon et al. 2022).”
Castro, C., Delwarde, C., Shi, Y., & Roh, J. D. (2025) · The Journal of Cardiovascular Aging · doi:10.20517/jca.2024.15 · Cited by 3
“Notably, all four ligands have been implicated in cardiac aging and HF, with the first three also being components of the SASP [148] .”
Aversa, Z., Frank, R. D., Geske, J. R., White, T. A., Heeren, A. A., Kapoor, E., Rocca, W. A., Schafer, M. J., Fields, J. A., Kantarci, K., et al. (2025) · Maturitas · doi:10.1016/j.maturitas.2025.108606 · Cited by 2
Oligodendroglia in Ageing and Age-Dependent Neurodegenerative Diseases
Niu, J., Verkhratsky, A., Butt, A. M., & Yi, C. (2025) · Advances in neurobiology · doi:10.1007/978-3-031-87919-7_13 · Cited by 5
Dehkordi, S. K., Sajedi, S., Heshmat, A., Orr, M. E., & Zare, H. (2025) · npj Aging · doi:10.1038/s41514-025-00235-y · Cited by 3
Insights into embryo-endometrium immune interactions
Ramhorst, R., Materazzi, L., Schafir, A., Castagnola, L., Fernández, L., Soczewski, E., Grasso, E., Martinez, G., Gnocchi, D., Cattaneo, A., et al. (2025) · Placenta · doi:10.1016/j.placenta.2025.08.332 · Cited by 4
Bury, A. G., Olejnik, A., Tocco, C., Saurat, N. G., Stephen, E., Hockemeyer, D. F., Schwamborn, J. C., Studer, L., Mastroberardino, P. G., Bolognin, S., et al. (2025) · npj Parkinson s Disease · doi:10.1038/s41531-025-01137-2 · Cited by 6
(2026) · doi:10.1161/jaha.125.047447 · Cited by 2
“Previous studies show an acceleration of the aging trajectory consequent to chronic and acute diseases, 4,43,44 including degenerative conditions.”
Interaction of tumor cells and Cancer-associated fibroblasts in radiation-induced senescence
Kupka, J. R., Gieringer, R., Kaya, S., Langer, V., Brieger, J., & Wiesmann, N. (2025) · Cellular Signalling · doi:10.1016/j.cellsig.2025.112187 · Cited by 2
MRTF-dependent cytoskeletal dynamics drive efficient cell cycle progression
Nielsen, J. C., Benito-Jardón, M., Petrela, N. C., Diring, J., Bellamy, S., & Treisman, R. (2024) · Journal of Cell Science · doi:10.1242/jcs.264444 · Cited by 4
“Mrtfab − / − MEFs exhibited elevated expression of senescence-associated secretory phenotype (SASP) factors (Acosta et al., 2013), including secreted proteins ( Il6 , Mmp2 , Hgf ), cellular receptors ( Tgfb2 , Tgfb3 , Tgfbi , Tlr2 ) and downstream effectors ( Btg2 , Irak1 , Irak2 ) (Fig.”
A systematic characterization of fibroblast subtypes and heterogeneity
Zhu, X. H., Kang, H., Zhao, Z., & Jia, P. (2025) · iScience · doi:10.1016/j.isci.2025.113915 · Cited by 2
Space radiation induces distinct senescent phenotypes: Implications for space travel
Pitcher, L. E., Mukherjee, B., Saathoff, A. M., Eduvas, Z. A., Bartz, J., Zhang, X., Giorgadze, N., Pirtskhalava, T., Habib, A. A., LeBrasseur, N. K., et al. (2025) · npj Aging · doi:10.1038/s41514-025-00272-7 · Cited by 5
Ren, Q., Rong, X., Liu, T., Zhang, Z., Zhang, W., Liu, H., Guan, S., & Li, M. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117586 · Cited by 2
Wang, X., Feng, Z., Sun, S., Zhang, J., Wang, K., Wang, Y., Zhao, Y., Zhao, B., Liu, B., Sun, M., et al. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102983 · Cited by 4
Hong, E., Yang, G., Oh, S., & Kim, E. (2025) · BioFactors · doi:10.1002/biof.70069 · Cited by 2
“Accumulating senescent cells remodel the tissue microenvironment via SASP factors, propagating cellular senescence to neighboring cells with age [7].”
Makulyte, G., Safwan‐Zaiter, H., Goehrig, D., Huna, A., Mangelinck, A., Mikawa, T., Palazzo, A., Moudombi, L., Médard, J., Chanal, M., et al. (2025) · Aging Cell · doi:10.1111/acel.70307 · Cited by 3
Meng, L., Zhang, H., Qiu, Y., Zhu, X., Ji, X., Wang, B., Zhang, G., Xue, Y., & Wang, C. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1727099 · Cited by 3
Fan, W., Huang, J., Guo, Z., Zhong, A., Tong, X., Li, X., Li, W., Chen, Y., Chen, Y., Lin, X., et al. (2026) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2026.178541 · Cited by 3
Of Barriers and Loops—How Evolution Limits Most Cancer Risks to Older Ages
Dominici, M. D., & DeGregori, J. V. (2026) · Cancer Discovery · doi:10.1158/2159-8290.cd-25-0779 · Cited by 4
Netti, G. S., Spadaccino, F., Lucarelli, G. T., Catalano, V., Checchia, A. A., Stasi, A., Luca, F. D., Camporeale, V., Leccese, G., Cuttano, R., et al. (2026) · Cancers · doi:10.3390/cancers18030414 · Cited by 3
He, Z., Bai, X., Xie, F., Wang, X., Zhang, F., Yu, Y., Yuan, Y., & Liu, C. (2026) · Advanced Science · doi:10.1002/advs.202521619 · Cited by 5
Frailty in People with HIV Is Linked to Inflammation, Bone Health, and T-Cell Exhaustion
Freeman, M. L., Fitzgerald, W., Clagett, B. M., O’Hare, K. A., Jonnalagadda, V., Wilson, B. M., Margolis, L. B., Wu, K., Tassiopoulos, K., Shive, C. L., et al. (2026) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiag046 · Cited by 4
Uemura, K., Hiro, S., Attachaipanich, S., Du, R., Yusof, N. I. S. M., Kinoshita, M., Hikosaka, M., & Ohtsuki, G. (2026) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2025.1669272 · Cited by 7
Shikama, Y., Yoshida, K., & Shikama, Y. (2026) · BioFactors · doi:10.1002/biof.70087 · Cited by 2
“Moreover, IL-1 signaling has been shown to induce cellular senescence [46], and we herein revealed that the IL-1β treat-ment increased γH2A.”
Zhao, Y. (2026) · Biogerontology · doi:10.1007/s10522-026-10410-7 · Cited by 3
“…emphasizing the transmission role of SASP and EVs, explains how senescence spreads from local "hotspots" to tissue-level or even systemic "burdens" (Acosta et al. 2013); and attempts to associate aging accumulation during an individual’s life cycle with the evolutionary adaptation and disease…”
Targeting Cellular Senescence: A New Therapeutic Axis in Chronic Liver Disease
Li, J., Xiang, Z., Xu, Y., Luo, X., Jiang, Y. X., Huang, Y., Yang, Z., Chen, R., & (112147), X. X. (2026) · Engineering · doi:10.1016/j.eng.2026.02.019 · Cited by 4
Παπανικολάου, Κ., Yadav, A., Mankowski, R. T., Alexander, M. S., Gamboa, J. L., Thalacker‐Mercer, A. E., Dungan, C. M., & Englund, D. A. (2026) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00876.2025 · Cited by 2
Etoh, K., Hino, Y., Morishita, H., & Nakao, M. (2026) · Molecular Cell · doi:10.1016/j.molcel.2026.03.020 · Cited by 2
Goo, B. M. S. S., Ahmadieh, S., Veerapaneni, P., Shi, H., Kim, D. S., Ogbi, M., Chouhaita, R., Cyriac, N., Cave, S., Liu, L., et al. (2026) · Aging Cell · doi:10.1111/acel.70519 · Cited by 2
“Overexpression of TST in adipocytes protected mice from diet-induced obesity and insulin resistance and improved mitochondrial function (Acosta et al. 2013).”
Yılmaz, A., Park, H.-J., Ahn, E., & Bae, J. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27093930 · Cited by 5
“One of the defining features of senescent cells is the SASP [96].”
The role of cellular senescence in metabolic dysfunction-associated steatotic liver disease
Wen, R., Wang, H., Xie, J., Lin, X., & Wang, S. (2026) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2026.07.003 · Cited by 4
Restored clearance of senescent neutrophils by tissue-resident macrophages limits organ aging
Tan, Y. J., Conley, T. E., Yao, F., Garcia-Marques, F. J., Akinyemi, D. E., Dinh, V. V., Wang, Q., Bermudez, A., Kim, J., Belk, J. A., et al. (2026) · Science · doi:10.1126/science.aea3075 · Cited by 11
Senotypes define the diverse landscape of senescent cells
Schafer, M. J., Basisty, N., Hertzel, A. V., Rindone, A. N., Elisseeff, J. H., Suryadevara, V., Aliferis, C., Robbins, P. D., Niedernhofer, L. J., Miller, K. N., et al. (2026) · Nature Aging · doi:10.1038/s43587-026-01148-5 · Cited by 7
“This can occur through paracrine SASP signaling 39 , juxtracrine cell-to-cell contact pathways such as NOTCH 40,42 and reactive oxygen species-mediated or gap-junction-mediated bystander effects 41 .”
Molecular mechanisms and pathogenesis of MASH
Gallage, S., Govaere, O., Anstee, Q. M., Shulman, G. I., Tacke, F., & Heikenwälder, M. F. (2026) · Nature · doi:10.1038/s41586-026-10529-0 · Cited by 10
“Their secretome, termed the senescence-associated secretory phenotype (SASP), includes proinflammatory chemokines and cytokines, proteases and growth factors that may either reinforce the growth arrest or promote tumorigenesis depending on the context and the recipient cells 189–191 .”
Pro-senescence Therapy for Cancer: Time for the Clinic
Kalathur, M., Mitri, D. D., & Alimonti, A. (2014) · Springer eBooks · doi:10.1007/978-94-017-9421-3_8 · Cited by 2
Mitochondrial Stress and Cellular Senescence
Tan, I. L., & Velarde, M. C. (2019) · CRC Press eBooks · doi:10.1201/9780429443336-29 · Cited by 2
Oxidative Stress, Metabolism and Photoaging – The Role of Mitochondria
Jackson, M. J., Naidoo, K., & Birch‐Machin, M. A. (2019) · Royal Society of Chemistry eBooks · doi:10.1039/9781788015981-00105 · Cited by 2
Dhalla, P. S., Kaul, A., Garcia, J., Bapatla, A., Khalid, R., Armenta-Quiroga, A. S., & Khan, S. (2020) · Cureus · doi:10.7759/cureus.10794 · Cited by 5
“The full-length p53 desirable outcomes are suppressing pre-malignant tumor cells resulting in tumor suppression, getting rid of damaged cells by stimulating the immune system, and supporting reparative mechanisms like tissue restoration and wound healing [33-35].”
BackgroundSelf-citationChang, S.-C., Hsu, C., Liu, L.-K., Lu, Y., Tsai, Y.-L., Chou, R., Huang, P., Chen, L., & Lin, S. (2021) · Scientific Reports · doi:10.1038/s41598-021-99081-7 · Cited by 2
Cellular senescence during aging and chronic liver diseases
Jurk, D. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822514-1.00005-5 · Cited by 2
Payea, M. J., Gorospe, M., & Basisty, N. (2022) · Journal of Visualized Experiments · doi:10.3791/63835 · Cited by 2
Takaya, K., Asou, T., & Kishi, K. (2023) · Rejuvenation Research · doi:10.1089/rej.2023.0020 · Cited by 2
Sex difference and immunosenescence affect transplantation outcomes
Maenosono, R. (2023) · Frontiers in Transplantation · doi:10.3389/frtra.2023.1235740 · Cited by 3
Senescence detection using reflected light
Dedic, B., Westerberg, L. J. S., Solís, A. M., Dumont, K. D., Ruas, J. L., Thorell, A., Näslund, E. B., & Spalding, K. L. (2024) · Aging Cell · doi:10.1111/acel.14295 · Cited by 2
Fu, C., Tian, X., Wu, S., Chu, X., Cheng, Y., Wu, X., & Yang, W. (2024) · Frontiers in Genetics · doi:10.3389/fgene.2024.1447296 · Cited by 6
Cellular senescence and its pathogenic and therapeutic implications in autoimmune hepatitis
Czaja, A. J. (2024) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2024.2432480 · Cited by 2
“The senescence of hepatocytes induced by the oxidative stress of chronic inflammation [10,22,23,85] may help explain the suboptimal responses of autoimmune hepatitis to conventional glucocorticoid-based therapy [103].”
InfluentialBi, J., Zeng, J., Liu, X., Mo, C., Yao, M., Zhang, J., Yuan, P., Jia, B., & Xu, S. (2024) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2024.102209 · Cited by 2
“Simultaneously, the SASP secreted by senescent cells deteriorates the cell microenvironment (Acosta, 2013).”
Yamazaki, H., & Ando, H. (2025) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.13219 · Cited by 4
“However, because senescent cells are known to transform surrounding cells into senescent ones through the senescence-associated secretory phenotype (SASP) (Acosta et al. 2013), ultimately resulting in a spread of senescent cells that accumulate melanin in that area, leading to the appearance of spots.”
Current Methodologies to Assess Cellular Senescence in Cancer
Laouris, P., & Muñoz‐Espín, D. (2025) · Methods in molecular biology · doi:10.1007/978-1-0716-4426-3_2 · Cited by 4
Kim, D., Kang, S., Jun, S., & Kang, N. (2025) · Natural Product Communications · doi:10.1177/1934578x251338519 · Cited by 3
Zheng, X., Jiang, G.-J., & Fan, T. (2025) · Current Eye Research · doi:10.1080/02713683.2025.2497330 · Cited by 3
A p16 pathway to prevention: Senescence as a driver of tau-mediated neurodegeneration
Lam, J. Y. L., Wang, K., & Bu, G. (2025) · Neuron · doi:10.1016/j.neuron.2025.06.024 · Cited by 2
Inflammation in Chronic Kidney Disease
Cobo, G., Jankowska, M., Stenvinkel, P., & Lindholm, B. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-52978-5.00014-8 · Cited by 3
To Find and Destroy: Identification and Elimination of Senescent Cells
Borodkina, A. V., Deryabin, P. I., Griukova, A., & Nikolsky, N. N. (2018) · Biochemistry (Moscow) Supplement Series A Membrane and Cell Biology · doi:10.1134/s1990747818030030 · Cited by 3
Bases moléculaires du vieillissement rénal
Cohen, C. (2021) · Néphrologie & Thérapeutique · doi:10.1016/j.nephro.2020.02.006 · Cited by 3
Khosla, S., Monroe, D. G., & Farr, J. N. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822514-1.00011-0 · Cited by 2
Cellular lifespan and senescence: a complex balance between multiple cellular pathways
Dolivo, D., Hernandez, S. J., & Dominko, T. (2015) · Inside the Cell · doi:10.1002/icl3.1036 · Cited by 3
Wang, J., Yano, S., Xie, K., Ohata, Y., & Hara, T. (2022) · Genes · doi:10.3390/genes13060974 · Cited by 4
“A previous study showed that UVA radiation induced oxidative stress in mouse dermal cells, and that dermal cells secreted matrix metalloproteinase-1 to modulate epidermal keratinocytes [19], suggesting that senescent cells can induce paracrine senescence in normal neighboring cells via secretion of SASP factors [35].”
BackgroundCurrent mechanisms in the pathogenesis of lung fibrosis
Engin, M. M. N., & Özdemır, Ö. (2023) · Trends in Immunotherapy · doi:10.24294/ti.v7.i1.2028 · Cited by 2
Extracellular Vesicles and Cardiac Aging
Seara, F. D. A. C., Maciel, L., Kasai-Brunswick, T. H., Nascimento, J. H. M., & de Carvalho, A. C. C. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-981-99-1443-2_3 · Cited by 2
Zhao, Q., Su, S., Lin, Y., Li, X., Dan, L., Yang, C., Geng, C., Regazzi, R., Li, X., Dong, Y., et al. (2023) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2808181 · Cited by 2
“Thirdly, the causal relationship between senescence and inflamma-14 tion in stearic acid-induced β -cell dysfunction needs to be determined because the release of senescence-associated secretory phenotype proteins worsens surrounding cells leading to senescence [40] and inflammation [41].”
BackgroundSwanson, E. C. (2014) · The Journal of the American Medical Association (JAMA) Network (American Medical Association) · doi:10.13028/m2k30f · Cited by 1
“, 2008) while others can induce a senescence response in their neighbors (Acosta et al., 2013; Nelson et al., 2012).”
BackgroundInfluentialThe Connection between Cellular Senescence and Age-Related Diseases
Falandry, C. (2019) · Cambridge University Press eBooks · doi:10.1017/9781316677018.005 · Cited by 2
Interconnection Between Cellular Senescence, Regeneration and Ageing in Salamanders
Yu, Q., & Yun, M. H. (2020) · Healthy ageing and longevity · doi:10.1007/978-3-030-44903-2_3 · Cited by 2
Gremlin 2 increased in the skin with age as a senescence‐associated secretory phenotype factor
Kawagishi‐Hotta, M., Hasegawa, S., Hasebe, Y., Sugiura, K., & Akamatsu, H. (2020) · The Journal of Dermatology · doi:10.1111/1346-8138.15578 · Cited by 2
Mechanisms of cell senescence in aging
von Zglinicki, T. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-815962-0.00003-2 · Cited by 3
Human ageing, a biological view
Almeida, H., & Matos, L. (2015) · Wiley eBooks · doi:10.1002/9781118823408.ch1 · Cited by 2
“RAMESH Date: 31 Jan 2015 Time: 12:03:18 PM Stage: Printer WorkFlow:CSW Page Number: 12 2011); and they induce senescence in normal surrounding cells (Acosta et al., 2013).”
Background
Metadata
- Authors
- Acosta, J. C., Banito, A., Wuestefeld, T., Georgilis, A., Janich, P., Morton, J. P., Athineos, D., Kang, T.-W., Lasitschka, F., Andrulis, M., Pascual, G., Morris, K. J., Khan, S., Jin, H., Dharmalingam, G., Snijders, A. P., Carroll, T., Capper, D., Pritchard, C., Inman, G. J., Longerich, T., Sansom, O. J., Benitah, S. A., Zender, L., & Gil, J.
- Affiliations
- Imperial College London (GB)
- Centre for Genomic Regulation (ES)
- Cancer Research UK Scotland Institute (GB)
- University of Tübingen (DE)
- German Cancer Research Center (DE)
- University of Leicester (GB)
- University of Dundee (GB)
- Corresponding author
- Gil, Jesús
- ORCID
- Acosta, Juan Carlos
- Banito, Ana
- Janich, Peggy
- Morton, Jennifer P.
- Athineos, Dimitris
- Lasitschka, Felix
- Andrulis, Mindaugas
- Pascual, Gloria
- Khan, Sadaf
- Jin, Hong
- Snijders, Ambrosius P.
- Carroll, Thomas
- Capper, David
- Pritchard, Catrin
- Inman, Gareth J.
- Longerich, Thomas
- Sansom, Owen J.
- Benitah, Salvador Aznar
- Zender, Lars
- Gil, Jesús
- Venue
- Nature Cell Biology
- Published
- 2013-06-16
- Volume
- 15
- Issue
- 8
- Pages
- 978-990
- ISSN
- 1465-7392 (ISSN-L)
- 1476-4679
- PMC
- PMC3732483
- OpenAlex
- W2140930678
- Semantic Scholar
- 59786bed7ce43f9317328cd82838f14d911e5dd4
- Cited by
- 2,278
- References
- 54
- Citations by year
- 2026: 247 · 2025: 225 · 2024: 232 · 2023: 240 · 2022: 264 · 2021: 250 · 2020: 202 · 2019: 154 · 2018: 119 · 2017: 107 · 2016: 89 · 2015: 79 · 2014: 56 · 2013: 13
- FWCI
- 54.88
- Type
- journal article
- Language
- en
- Update notices
- correction (2026-04-28)
- Open access
- green
- europepmc.org
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- NERC Open Research Archive (Natural Environment Research Council) (acceptedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RECERCAT (Consorci de Serveis Universitaris de Catalunya) (acceptedVersion, other-oa)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
- Repositori digital de la UPF (Universitat Pompeu Fabra) (submittedVersion)
- Spiral (Imperial College London) (submittedVersion)
- Funders
- Cancer Research UK (A7769, 13083, 11650, 12481)
- Medical Research Council
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Keywords
- oncogene-induced senescence, senescence-associated secretory phenotype, paracrine senescence, inflammasome, IL-1 signaling, TGF-beta ligands, vascular endothelial growth factor, MCP-1, CCL20, CDKN2B, p21, tumor suppression, senescence-associated secretome
- MeSH terms
- Animals, Colonic Neoplasms, Humans, Immunohistochemistry, Interleukin-1, Protein Binding, Signal Transduction, Gene Expression Regulation, Neoplastic, Cellular Senescence, Paracrine Communication, Models, Animal, Cell Line, Tumor, Mice, Transforming Growth Factor beta1, Inflammasomes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-12, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-12 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.